跳至主要内容
临床试验/CTRI/2019/06/019876
CTRI/2019/06/019876尚未招募未知

Effect of Pre-Operative transarterial embolisation (TAE)on circulating tumour cells and recurrence in hepatocellular carcinoma - TAE CTC

Tata Memorial Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • All patients of HCC deemed resectable, (based on clinico-radiological criteria with or without histological diagnosis) after Joint clinic discussion will be counseled for getting enrolled in the study
  • Following patients with HCC are considered for resection and will be encouraged to participate in the study
  • Non metastatic HCC in a non-cirrhotic or a Childs A cirrhotic patient if adequate FLR (future liver remnant) can be ensured post resection and if R0 resection can be achieved
  • Solitary HCC, more than 5 cm in size.
  • Low volume (few lesions - up to 4) multicentric disease, localizedin one lobe if can be completely resected

排除标准

  • Patients of HCC planned in Joint clinic for treatment options other than resection.
  • Patients enrolled but intra operatively found to be inoperable
  • Patients refusing to participate in the study.

研究者

相似试验